Features of examination and systemic treatment of malignant neoplasms in gerontological patients
- Authors: Semiglazova T.Y.1,2, Alekseeva Y.V3, Tkachenko E.V3, Sharashenidze S.M3, Baldueva I.A3, Volchenkov S.A3, Kovyazin A.K3, Filatova L.V1,2, Kasparov B.S3, Semiglazov V.V3,4, Protsenko S.A3, Anisimov V.N3, Belyaev A.M3,4
-
Affiliations:
- N. Petrov National Medical Research Center of Oncology
- North-Western State Medical University n.a. I.I. Mechnikov
- N.N. Petrov National Medical Research Center of Oncology
- Pavlov University
- Issue: Vol 28, No 7 (2021)
- Pages: 138-145
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/313191
- DOI: https://doi.org/10.18565/pharmateca.2021.7.138-145
- ID: 313191
Cite item
Abstract
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
T. Yu Semiglazova
N. Petrov National Medical Research Center of Oncology; North-Western State Medical University n.a. I.I. Mechnikov
Email: tsemiglazova@mail.ru
St. Petersburg, Russia
Yu. V Alekseeva
N.N. Petrov National Medical Research Center of OncologySt. Petersburg, Russia
E. V Tkachenko
N.N. Petrov National Medical Research Center of OncologySt. Petersburg, Russia
S. M Sharashenidze
N.N. Petrov National Medical Research Center of OncologySt. Petersburg, Russia
I. A Baldueva
N.N. Petrov National Medical Research Center of OncologySt. Petersburg, Russia
S. A Volchenkov
N.N. Petrov National Medical Research Center of OncologySt. Petersburg, Russia
A. K Kovyazin
N.N. Petrov National Medical Research Center of OncologySt. Petersburg, Russia
L. V Filatova
N. Petrov National Medical Research Center of Oncology; North-Western State Medical University n.a. I.I. MechnikovSt. Petersburg, Russia
B. S Kasparov
N.N. Petrov National Medical Research Center of OncologySt. Petersburg, Russia
V. V Semiglazov
N.N. Petrov National Medical Research Center of Oncology; Pavlov UniversitySt. Petersburg, Russia
S. A Protsenko
N.N. Petrov National Medical Research Center of OncologySt. Petersburg, Russia
V. N Anisimov
N.N. Petrov National Medical Research Center of OncologySt. Petersburg, Russia
A. M Belyaev
N.N. Petrov National Medical Research Center of Oncology; Pavlov UniversitySt. Petersburg, Russia
References
- Анисимов В.Н., Беляева А.М. (ред.). Онкогеронтология: Руководство для врачей. СПб., 2017. 512 с
- Lichtman S.M. Therapy insight: Therapeutic challenges in the treatment of elderly cancer patients. Nat Clin Pract Oncol. 2006;3(2):86-93. doi: 10.1038/ncponc0420.
- Wildiers H, Heeren P, Puts M., et al. International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer. J Clin Oncol. 2014;32:2595-603. Doi: 10.1200/ JCO.2013.54.8347.
- Kumar A, Soares H.P, Balducci L., Djulbegovic B. National Cancer Institute. Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groups. J Clin Oncol. 2007;25(10):1272-76. doi: 10.1200/JCO.2006.09.2759.
- Mohile S.G., Mohamed M.R., Culakova E., et al. A geriatric assessment (GA) intervention to reduce treatment toxicity in older patients with advanced cancer: A University of Rochester Cancer Center NCI community oncology research program cluster randomized clinical trial (CRCT). J Clin Oncol. 2020;38:12009a. Doi: 10.1200/ JCO.2020.38.15_suppl.12009.
- Hurria A. Senior adult oncology, version 2.2014. J Natl Compr Cancer Netw. 2014;12:82-126. doi: 10.6004/jnccn.2014.0009.
- Yu M, Hazelton W.D., Luebeck G.E., Grady W.M. Epigenetic Aging: More Than Just a Clock When It Comes to Cancer. Cancer Res. 2020;80(3):367-74. doi: 10.1158/0008-5472.CAN-19-0924.
- Aapro M.S, Schrijvers D., et al. ESMO handbook of cancer in the senior patient. 2nd edition. 2015.
- Balducci L., Corcoran M.B. Antineoplastic chemotherapy of the older cancer patient. Hematol. Oncol Clin North Am. 2000;14(1):193-212, x-xi. doi: 10.1016/s0889-8588(05)70284-7.
- Hurria A., Lichtman S.M. Clinical pharmacology of cancer therapies in older adults. Br J Cancer. 2008;98(3):517-22. Doi: 10.1038/ sj.bjc.6604201.
- Balducci L., Extermann M. Cancer and aging. An evolving panorama. Hematol Oncol Clin North Am. 2000;14(1):1-16. doi: 10.1016/s0889-8588(05)70274-4. PMID: 10680068.
- Переводчикова Н.И., Горбунова В.А. (ред.). Руководство по химиотерапии опухолевых заболеваний. 4-е изд. расширенное и допол. М., 2018. 688 с.
- Dombret H., Raffoux E., Gardin C. Acute myeloid leukemia in the elderly. Semin Oncol. 2008;35(4):430-38. Doi: 10.1053/j. seminoncol.2008.04.013.
- Repetto L., Fratino L., Audisio R.A., et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20(2):494-502. doi: 10.1634/theoncologist.5-3-224.
- Balducci L., Repetto L. Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma. Cancer. 2004;100(1):6-11. doi: 10.1002/cncr.11861.
- Doorduijn J.K., van der Holt B., van Imhoff G.W., et al. CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2003;21(16):3041-50. Doi: 10.1200/ JCO.2003.01.076.
- Gomez H., Mas L., Casanova L., et al. Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity. J Clin Oncol. 1998;16(7):2352-58. doi: 10.1200/JCO.1998.16.7.2352.
- Lyman G.H., Kuderer N.M., Djulbegovic B. Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis. Am J Med. 2002;112(5):406-11. doi: 10.1016/s0002-9343(02)01036-7.
- Patel K.V Epidemiology of anemia in older adults. Semin Hematol. 2008;45(4):210-17. doi: 10.1053/j.seminhematol.2008.06.006.
- Procter M., Suter T.M., de Azambuja E., et al. Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial. J Clin Oncol. 2010;28(21):3422-doi: 10.1200/JCO.2009.26.046.
- Chavez-MacGregor M., Zhang N., Buchholz T.A., et al. Trastuzumab-related cardiotoxicity among older patients with breast cancer. J Clin Oncol. 2013;31(33):4222-28. Doi: 10.1200/ JCO.2013.48.7884.
- Miles D., Baselga J., Amadori D., et al. Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). Breast Cancer Res Treat. 2013;142(1):89-99. doi: 10.1007/s10549-013-2710-z [Epub 2013 Oct 16].
- Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. Published ahead of print May 21, 2018. doi: 10.1200/JC0.2018.78.8687.
- Kanesvaran R, Cordoba R, Maggiore R. Immunotherapy in Older Adults With Advanced Cancers: Implications for Clinical Decision-Making and Future Research. Am Soc Clin Oncol. Educ Book. 2018;38:400-14. doi: 10.1200/EDBK 201435.
- Wu Q, Wang Q, Tang X., et al. Correlation between patients' age and cancer immunotherapy efficacy. Oncoimmunol. 2019;8(4):e1568810. doi: 10.1080/2162402X.2019.1568810.
- Hong H, Wang Q, Li J, et al. Aging, Cancer and Immunity. J Cancer. 2019;10(13):3021-27. doi: 10.7150/jca.30723.
- NCCN Older Adult Oncology Guidelines Version 1.2020. URL: https://www.nccn.org/ professionals/physician_gls/pdf/senior.pdf
- Soto-Perez-de-Celis E, Aapro M, Muss H. ASCO 2020: The Geriatric Assessment Comes of Age. Oncol. 2020;25(11):909-12. Doi: 10.1634/ theoncologist.2020-0804.
- Hamaker M.E., Schiphorst A.H., ten Bokkel H.D., et al. The effect of a geriatric evaluation on treatment decisions for older cancer patients-a systematic review. Acta Oncol. 2014;53:289-96. doi: 10.3109/0284186X.2013.840741.
- Decoster L, Vanacker L, Kenis C, et al. Relevance of Geriatric Assessment in Older Patients With Colorectal Cancer. Clin. Colorectal. Cancer. 2017;16(3):221-29. Doi: 10.1016/j. clcc.2016.07.010.
Supplementary files
![](/img/style/loading.gif)